当前位置: 首页 > 详情页

The treatment effect of diazoxide on 44 patients with congenital hyperinsulinism

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Capital Med Univ, Beijing Childrens Hosp, Endocrine & Genet Metab Ctr,Minist Educ, Natl Key Discipline Pediat,Dept Endocrinol, Beijing 100045, Peoples R China; [2]Capital Med Univ, Beijing Childrens Hosp, Endocrine & Genet Metab Ctr,Minist Educ, Natl Key Discipline Pediat,Dept Endocrinol, Fuxingmenwai Nanlishi Rd 56, Beijing 100045, Peoples R China
出处:
ISSN:

关键词: congenital hyperinsulinism diazoxide side effect

摘要:
Objective: To study the treatment effect and safety of diazoxide on patients with congenital hyperinsulinism (CHI). Research design and methods: A total of 44 patients who have been hospitalized to our hospital and used diazoxide as a trial after diagnosis of CHI were chosen as research subjects. The clinical data of the patients were analyzed, and the treatment effects and safety of diazoxide on CHI were evaluated. Results: In the 44 patients studied, the blood glucoses of 36 cases recovered to normal level after using diazoxide, indicating that the 36 patients respond to the treatment of diazoxide. Eight cases still showed severe hypoglycemia after using diazoxide for 10 days, which indicated that the eight patients were unresponsive to diazoxide treatment. Eighteen patients suffered the side effect of fluid retention, and 12 patients suffered transient gastrointestinal reactions. Conclusion: Diazoxide is a first-line treatment of CHI with high safety. Most of the patients with CHI were responsive to diazoxide treatment. Diazoxide should be used as a trial immediately after CHI diagnosis was made.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2011]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢 4 区 儿科
最新[2023]版:
大类 | 4 区 医学
小类 | 4 区 内分泌学与代谢 4 区 儿科
JCR分区:
出版当年[2010]版:
Q4 ENDOCRINOLOGY & METABOLISM Q4 PEDIATRICS
最新[2023]版:
Q3 PEDIATRICS Q4 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2010版] 出版当年五年平均 出版前一年[2009版] 出版后一年[2011版]

第一作者:
第一作者机构: [1]Capital Med Univ, Beijing Childrens Hosp, Endocrine & Genet Metab Ctr,Minist Educ, Natl Key Discipline Pediat,Dept Endocrinol, Beijing 100045, Peoples R China; [2]Capital Med Univ, Beijing Childrens Hosp, Endocrine & Genet Metab Ctr,Minist Educ, Natl Key Discipline Pediat,Dept Endocrinol, Fuxingmenwai Nanlishi Rd 56, Beijing 100045, Peoples R China
通讯作者:
通讯机构: [1]Capital Med Univ, Beijing Childrens Hosp, Endocrine & Genet Metab Ctr,Minist Educ, Natl Key Discipline Pediat,Dept Endocrinol, Beijing 100045, Peoples R China; [2]Capital Med Univ, Beijing Childrens Hosp, Endocrine & Genet Metab Ctr,Minist Educ, Natl Key Discipline Pediat,Dept Endocrinol, Fuxingmenwai Nanlishi Rd 56, Beijing 100045, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院